Updated
Updated · Yahoo Finance · Aug 25
Peptide Synthesis Market to Hit $1.54 Billion by 2031 as Services Grow 12.0%
Updated
Updated · Yahoo Finance · Aug 25

Peptide Synthesis Market to Hit $1.54 Billion by 2031 as Services Grow 12.0%

2 articles · Updated · Yahoo Finance · Aug 25

Summary

  • USD 1.54 billion is the projected size of the peptide synthesis market by 2031, up from USD 0.98 billion in 2026 at a 9.5% CAGR.
  • Pharma and biotech investment in peptide-based therapeutics, diagnostics and research is lifting demand for synthesizers, amino acids, resins, purification systems and analytical tools.
  • Services are set to expand fastest with a 12.0% CAGR, while reagents and consumables held the largest product share at 71.4% in 2025.
  • North America led the market with about 41.8% share in 2025 as suppliers pushed automated, high-throughput and custom synthesis offerings for more complex peptide formats.
  • The outlook also reflects rising outsourcing to CROs and CDMOs and a shift toward greener, more efficient workflows that cut cycle times, waste and purification burdens.

Insights

With GLP-1 drugs booming, could unexpected supply chain bottlenecks for complex resins derail the projected $1.54 billion peptide market by 2031?
Could the sudden rise of oral small molecule alternatives unexpectedly crash the soaring demand for large-scale injectable peptide manufacturing?
Will the urgent push for greener chemistry disrupt traditional solid-phase peptide synthesis before automated manufacturing pipelines can adapt?